Upgraded Life Festival (ULF) is an annual highlight in the Nordic health tech calendar that aims to connect startup pioneers by partnering them with established healthcare powerhouses. This year’s event in Helsinki was no exception, with visitors including startups, industry insiders, investors, public sector experts and academic researchers.
Organized by Upgraded, the Health Startup Association of Finland, ULF further consolidates Helsinki’s position as a world-leading hub for health innovation, with the city being home to over 300 life science companies (whose combined revenue exceeds $1.5 billion USD).
Nightingale was proud to feature as one of the companies invited to showcase its innovative technology at ULF 18, with Nightingale’s CEO, Teemu Suna, participating in a keynote panel discussion. Entitled “How to invest 20 million?,” the session touched upon Lauri Sippola (Kaiku Health's CEO) and Teemu’s insights and experience in utilizing early stage investments to accelerate future business growth. When asked about what advice should be given to health startups in Finland, Teemu replied that he only had one word – ambition.
“People like to talk about the technology developed in Finland because it’s among the very best in the world. Outside of Finland however, some people can fail to believe in these innovations as the companies that developed them don't back them up with enough ambition,” Teemu added. “Evidence generation is vital to success in life sciences. You must be able to provide the evidence that proves your technology works, along with an emotional commitment that can convincingly explain why your technology is important to society.”